Novo Nordisk Gains 0.62% on £410m Trade Amid GLP-1 Market Volatility and Innovation Push
Novo Nordisk, the Danish pharmaceutical giant best known for its obesity and diabetes treatments, saw its shares edge 0.62% higher…
Home »
GLP-1 Market
Novo Nordisk, the Danish pharmaceutical giant best known for its obesity and diabetes treatments, saw its shares edge 0.62% higher…
